the cardiovascular effects of 10% and 2.5% topical aqueous phenylephrine.
Methods We carried out a double-masked randomised study on 54 consecutive patients undergoing routine local anaesthetic cataract extraction, comparing the effects on blood pressure and heart rate of either 2.5% or 10% topical aqueous phenylephrine in combination with 1% topical aqueous tropicamide in those with no history of cardiovascular disease.
Results No difference was found in the rise in blood pressure produced by 2.5% and 10% topical aqueous phenylephrine. We also found no sustained changes in blood pressure or heart rate after instillation of either 2.5% or 10% topical aqueous phenylephrine.
Conclusion
We recommend the routine use of 2.5% topical aqueous phenylephrine as a mydriatic agent during cataract surgery and acknowledge the role of 10% topical aqueous phenylephrine as an effective mydriatic agent in cases where 2.5% phenylephrine may not be so effective, such as in subjects with darkly pigmented irides. Prior to instillation of eye drops blood pressure and pulse were measured. Each subject was then randomised, in a double-masked manner, to receive three consecutive drops of either 2.5% phenylephrine 
Statistical analysis
To investigate the effect on peak blood pressure changes the maximum increase above control of the systolic and diastolic blood pressure during the 80 min following installation of the drops was compared between the two groups using an analysis of variance. In addition sustained changes in blood pressure and heart rate were investigated by comparing the mean change in systolic and diastolic pressure and pulse rate during the 20-80 min after instillation. Statistical significance was taken as p :s; 0.05. 
Results
Fifty-four patients were recruited into the study, 56%
(n = 30) of whom were female. The mean age was 76.1 years (range 55-87 years). Mean weight was not recorded for all patients; however, only patients with an acceptable body mass index (20-30 calculated using the formula: Weight (kg)/Height (m) 2 ) were selected. 8
Twenty-eight patients received 2.5% phenylephrine and 26 patients received 10% phenylephrine. The incidence of hypertension in the two groups and baseline blood pressure and pulse rate values are shown in Table 1 .
Power calculation showed there was a 96% chance of detecting a 20 mmHg difference in blood pressure between the two groups and an 81 % chance of detecting a difference of 15 mmHg. There was no difference between the two groups in the mean peak systolic or diastolic blood pressure during the 80 min after instillation of the drops (Table 2) . Nor was there any difference between the two groups in the mean change in systolic blood pressure, diastolic blood pressure or heart rate from the baseline during the period 20-80 min after instillation of drops.
As there was no difference between the two groups they were combined for further analysis of mean systolic blood pressure, diastolic blood pressure and heart rate of the whole sample during the period of 20-80 min after instillation of drops. This found no difference when compared with the baseline values (Table 3) .
Retrospective analysis of our data found 59% of patients to be hypertensive (9 men, 11 women).
Hypertensive patients were defined either as those known to be hypertensive on oral treatment or as those having a baseline systolic pressure greater than 160 mmHg and/or diastolic pressure greater than 95 mmHg.
None of the patients required sedation nor developed severe hypertension or any other untoward event during the intraoperative or post-operative period. 
